EODData

MEMBERSHIP REGISTER LOG IN

SHE, 002653: Xizang Haisco Pharmaceutical Group Co Ltd

19 Dec 2025
LAST:

52.04

CHANGE:
 0.54		OPEN:
51.50		HIGH:
53.39		ASK:
0.00		VOLUME:
3.23M
CHG(%):
1.05		PREV:
51.50		LOW:
51.34		BID:
0.00		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
19 Dec 2551.5053.3951.3452.043.23M
18 Dec 2552.4052.4051.4851.501.72M
17 Dec 2552.6152.6651.4052.402.49M
16 Dec 2553.0753.0751.1852.173.22M
15 Dec 2554.7555.4952.5553.065.48M
12 Dec 2556.3856.5054.1254.707.16M
11 Dec 2558.5058.5055.6856.405.75M
10 Dec 2561.3561.3556.6858.484.62M
09 Dec 2561.8962.3660.7161.271.56M
08 Dec 2560.2062.5359.4461.472.79M

PROFILE

Name:Xizang Haisco Pharmaceutical Group Co Ltd
About:Haisco Pharmaceutical Group Co., Ltd. researches, develops, manufactures, and sells pharmaceutical products in China. The company offers anesthetic analgesic, neuropsychiatric system, and digestive liver and parenteral nutrition medications; drugs for the endocrine and cardiovascular system; oncology-related drugs; andrology drugs; desonide and liprocaine cream; propofol medium/long chain fat emulsion and hydroxyethyl starch sodium chloride injection; sodium fusidicate ointment; lupatadine fumarate tablets; and caspofungin acetate and methylprednisolone sodium succinate for injection. It also develops Sisuning for sedation and anesthesia during surgery/procedure for non-endotracheal intubation, general anesthesia induction and maintenance, sedation in mechanical ventilation during intensive care, pediatric indications, and general anesthesia induction; Simenine for diabetic peripheral neuralgia, postherpetic neuralgia, and central nervous system analgesia; Beichangping for type 2 diabetes; Sysojing for postoperative analgesia of abdominal surgery, chronic kidney disease itching, orthopedic analgesia, and postoperative nausea and vomiting; HSK31858 for non-cystic fibrosis bronchiectasis, bronchial asthma, chronic obstructive pulmonary disease, and expectorant; HSK31679 for nonalcoholic steatohepatitis; HSK39297 for PHN of hemolytic disease and primary or secondary glomerular disease; HSK39775 and HSK42360 for advanced solid tumors; HSK39004 and HL231 for chronic obstructive pulmonary disease; HSK44459 for interstitial lung disease; HSK46575 for prostate cancer; and HSK41959 for advanced solid tumors. It offers its products for anesthesia, analgesia, chronic metabolic, respiratory, autoimmune diseases, etc. The company was formerly known as Xizang Haisco Pharmaceutical Group Co., Ltd. and changed its name to Haisco Pharmaceutical Group Co., Ltd. in March 2016. Haisco Pharmaceutical Group Co., Ltd. was founded in 2005 and is based in Shannan, China.
Sector:Healthcare
Industry:Biotechnology
Address:No.17, Sanxiang Avenue, Shannan, China, 856000
Website:https://www.haisco.com
ISIN:CNE100001BC7

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:190.10 
Price to Sales:16.35 
Price to Book:16.00 
DivYield:0.00 
Div/Share:0.27 
Revenue:4.036B 
EBITDA:420.72M 
Shares:1.12B 
Market Cap:58.281B 

TECHNICAL INDICATORS

MA5:52.230.4%
MA10:55.356.4%
MA20:57.219.9%
MA50:54.825.3%
MA100:55.466.6%
MA200:48.786.7%
STO9:4.97 
STO14:4.90 
RSI14:22.61 
WPR14:-94.58 
MTM14:-7.33
ROC14:-0.12 
ATR:2.20 
Week High:56.508.6%
Week Low:51.181.7%
Month High:62.5320.2%
Month Low:51.186.7%
Year High:62.6520.4%
Year Low:29.1378.6%
Volatility:5.08 

RECENT SPLITS

Date Ratio
12 Sep 20131-1
11 Mar 201320-10

RECENT DIVIDENDS

Date Amount
15 May 2025$0.14
24 Jan 2025$0.14
18 Sep 2024$0.15
24 May 2024$0.20
05 Jul 2022$0.19
28 Apr 2021$0.37
03 Jul 2020$0.09
15 May 2019$0.19
02 Jul 2018$0.28
09 Jun 2017$0.46